Tapewire

Nasdaq · USD

INSM

INSMED Inc

Export transactions ↓
Tapewire entity
3174
SEC CIK
0001104506
Parsed reports
490

Last 12 months

Inside the activity.

0 purchase rows · 169 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 2025018
Jan 2026044
Feb 2026022
Mar 202608
Apr 2026010
May 2026019
Jun 2026013
Jul 202607
Aug 202604
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 08, 2025 Filed Jan 10, 2025 23:44 UTC
Smith Michael AlexanderChief Legal Officer
GrantCommon Stock 5,706 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 3

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,284

F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F5 · price: Each RSU was granted on January 8, 2025 for no consideration.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:44 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 1,064 $66.21 $70,447.44
Disclosure

SEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,578

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:44 UTC
Adsett RogerChief Operating Officer
GrantStock Option (right to buy) · Derivative 31,930 $0.00 Strike: $65.72 $0.00
Disclosure

SEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · derivative · entry 6

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,930

Underlying: Common Stock · 31,930 shares

Expires 2035-01-08

F7 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:44 UTC
Adsett RogerChief Operating Officer
GrantCommon Stock 6,657 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · nonDerivative · entry 3

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 152,441

F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.

F5 · price: Each RSU was granted on January 8, 2025 for no consideration.

Read SEC document
January 08, 2025 Filed Jan 10, 2025 23:44 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 1,882 $66.10 $124,400.20
Disclosure

SEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · nonDerivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,784

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 3,344 $65.91 $220,403.04
Disclosure

SEC source: 0001628280-25-001207 · wk-form4_1736552729.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,766

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 3,344 shares sold at prices ranging from $65.57 to $65.99 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3 · balance_after: Due to a clerical error related to the reporting of shares previously withheld by the Company to satisfy tax obligations upon the vesting of RSUs, this number was previously overstated by 24 shares. This value reflects the adjustment, decreasing the amount beneficially owned by 24 shares.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 3,470 $65.70 $227,979.00
Disclosure

SEC source: 0001628280-25-001206 · wk-form4_1736552720.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,736

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 3,470 shares sold at prices ranging from $65.69 to $65.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3 · balance_after: Includes 725 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 2,596 $65.88 $171,024.48
Disclosure

SEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,515

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,596 shares sold at prices ranging from $65.72 to $65.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3 · balance_after: Includes 11 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC
Wise John DraytonChief Commercial Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.07 $0.00
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · derivative · entry 7

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2025-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 2,908 $65.87 $191,549.96
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,584

F3 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

F4 · price: This is the weighted average sales price representing 2,908 shares sold at prices ranging from $65.84 to $65.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 10,000 $65.98 $659,800.00
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,492

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:45 UTC
Wise John DraytonChief Commercial Officer
Exercise / conversionCommon Stock 10,000 $16.07 $160,700.00
Disclosure

SEC source: 0001628280-25-001204 · wk-form4_1736552700.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:44 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 8,218 $66.02 $542,552.36
Disclosure

SEC source: 0001628280-25-001203 · wk-form4_1736552690.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,742

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 8,218 shares sold at prices ranging from $66.00 to $66.05 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:44 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 2,306 $65.98 $152,149.88
Disclosure

SEC source: 0001628280-25-001202 · wk-form4_1736552679.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,642

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,306 shares sold at prices ranging from $65.96 to $66.04 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3 · balance_after: Includes 92 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 23:44 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 2,444 $65.95 $161,181.80
Disclosure

SEC source: 0001628280-25-001201 · wk-form4_1736552668.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,666

F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,444 shares sold at prices ranging from $65.85 to $66.21 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3 · balance_after: Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 23:52 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,830 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · derivative · entry 7

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 225,460

Underlying: Common Stock · 6,830 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 23:52 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 18,750 $0.00 Strike: $22.76 $0.00
Disclosure

SEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · derivative · entry 6

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 18,750 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 23:52 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 6,830 $69.86 $477,143.80
Disclosure

SEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · nonDerivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 233,924

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 6,830 shares sold at prices ranging from $69.48 to $70.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 23:52 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 6,830 $10.85 $74,105.50
Disclosure

SEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 240,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 23:52 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 18,750 $69.84 $1,309,500.00
Disclosure

SEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 384,960

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 18,750 shares sold at prices ranging from $69.45 to $70.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 23:52 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 18,750 $22.76 $426,750.00
Disclosure

SEC source: 0001628280-25-000403 · wk-form4_1735948354.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 403,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
December 19, 2024 Filed Dec 20, 2024 21:25 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,830 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · derivative · entry 9

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 232,290

Underlying: Common Stock · 6,830 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
December 19, 2024 Filed Dec 20, 2024 21:25 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 18,750 $0.00 Strike: $22.76 $0.00
Disclosure

SEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · derivative · entry 8

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,500

Underlying: Common Stock · 18,750 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
December 19, 2024 Filed Dec 20, 2024 21:25 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 1,590 $70.61 $112,269.90
Disclosure

SEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 6

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 233,924

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · price: This is the weighted average sales price representing 1,590 shares sold at prices ranging from $70.36 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 19, 2024 Filed Dec 20, 2024 21:25 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 5,240 $69.71 $365,280.40
Disclosure

SEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 5

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 235,514

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 5,240 shares sold at prices ranging from $69.28 to $70.27 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 19, 2024 Filed Dec 20, 2024 21:25 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 6,830 $10.85 $74,105.50
Disclosure

SEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 240,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
December 19, 2024 Filed Dec 20, 2024 21:25 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 5,588 $70.52 $394,065.76
Disclosure

SEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 384,960

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 5,588 shares sold at prices ranging from $70.23 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 19, 2024 Filed Dec 20, 2024 21:25 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 13,162 $69.65 $916,733.30
Disclosure

SEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 390,548

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 13,162 shares sold at prices ranging from $69.22 to $70.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 19, 2024 Filed Dec 20, 2024 21:25 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 18,750 $22.76 $426,750.00
Disclosure

SEC source: 0001628280-24-052229 · wk-form4_1734729921.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 403,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,830 $0.00 Strike: $10.85 $0.00
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · derivative · entry 11

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 239,120

Underlying: Common Stock · 6,830 shares

Expires 2026-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 18,750 $0.00 Strike: $22.76 $0.00
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · derivative · entry 10

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,250

Underlying: Common Stock · 18,750 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F9 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 181 $74.22 $13,433.82
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 8

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 233,924

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F8 · price: This is the weighted average sales price representing 181 shares sold at prices ranging from $74.20 to $74.30 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 2,562 $73.55 $188,435.10
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 7

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 234,105

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F7 · price: This is the weighted average sales price representing 2,562 shares sold at prices ranging from $73.16 to $74.11 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 4,087 $72.57 $296,593.59
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 6

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 236,667

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · price: This is the weighted average sales price representing 4,087 shares sold at prices ranging from $72.05 to $73.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 6,830 $10.85 $74,105.50
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 5

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By the Katie Procter Dynasty Trust

Disclosed balance after: 240,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 399 $74.23 $29,617.77
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 384,960

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · price: This is the weighted average sales price representing 399 shares sold at prices ranging from $74.18 to $74.36 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 6,847 $73.56 $503,665.32
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 385,359

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 6,847 shares sold at prices ranging from $73.16 to $74.14 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 11,504 $72.58 $834,960.32
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 392,206

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 11,504 shares sold at prices ranging from $72.05 to $73.05 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 21:16 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 18,750 $22.76 $426,750.00
Disclosure

SEC source: 0001628280-24-051195 · wk-form4_1734124566.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 403,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
September 16, 2024 Filed Sep 16, 2024 20:46 UTC
Flammer Martina M.D.Chief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 13,436 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · derivative · entry 9

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,680

Underlying: Common Stock · 13,436 shares

Expires 2031-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
September 16, 2024 Filed Sep 16, 2024 20:46 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 13,436 $74.92 $1,006,625.12
Disclosure

SEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · nonDerivative · entry 6

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,134

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 13,436 shares sold at prices ranging from $74.90 to $75.17 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
September 16, 2024 Filed Sep 16, 2024 20:46 UTC
Flammer Martina M.D.Chief Medical Officer
Exercise / conversionCommon Stock 13,436 $34.03 $457,227.08
Disclosure

SEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · nonDerivative · entry 5

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionStock Option (right to buy) · Derivative 7,000 $0.00 Strike: $22.76 $0.00
Disclosure

SEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · derivative · entry 4

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,000 shares

Expires 2025-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 9,000 $74.75 $672,750.00
Disclosure

SEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 3

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,856

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 9,000 shares sold at prices ranging from $74.61 to $74.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC
Smith Michael AlexanderChief Legal Officer
SaleCommon Stock 18,871 $74.16 $1,399,473.36
Disclosure

SEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,856

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: This is the weighted average sales price representing 18,871 shares sold at prices ranging from $73.61 to $74.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:47 UTC
Smith Michael AlexanderChief Legal Officer
Exercise / conversionCommon Stock 7,000 $22.76 $159,320.00
Disclosure

SEC source: 0001628280-24-040523 · wk-form4_1726519651.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:46 UTC
Flammer Martina M.D.Chief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 26,969 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · derivative · entry 8

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,116

Underlying: Common Stock · 26,969 shares

Expires 2031-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:46 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 26,969 $74.90 $2,019,978.10
Disclosure

SEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · nonDerivative · entry 4

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,134

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 13, 2024 Filed Sep 16, 2024 20:46 UTC
Flammer Martina M.D.Chief Medical Officer
Exercise / conversionCommon Stock 26,969 $34.03 $917,755.07
Disclosure

SEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · nonDerivative · entry 3

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Read SEC document
September 12, 2024 Filed Sep 16, 2024 20:46 UTC
Flammer Martina M.D.Chief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 635 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001628280-24-040521 · wk-form4_1726519585.xml · derivative · entry 7

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,085

Underlying: Common Stock · 635 shares

Expires 2031-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.